President Moon talks with AZ CEO at G7 Summit

Green light expected in AZ’s long-term partnership with SK Bioscience

Korea will expand contributions to COVAX Advance Market Commitment (AMC) by 20 times

Government presents a cooperation plan for COVID-19 at G7 Summit

South Korean President Moon Jae-in met with Pascal Soriot, CEO of AstraZeneca, to ask for the company’s continuous support in supplying COVID-19 vaccines to Korea in the second half of this year.

 

AstraZeneca responded positively to the request and replied that it hopes to continue a long-standing relationship with SK Bioscience as one of its top CMO partners.

 

Also, the Korean government had announced its plan to increase contributions to the Gavi COVAX Advance Market Commitment (AMC) by 20 times to actively contribute to the inclusive recovery of the international community suffering from COVID-19.

 

The COVID-19 Central Disaster and Safety Countermeasures Headquarters (CDSCHQ, Prime Minister Kim Boo-Kyum) today (13th) had announced the president's participation at the G7 summit that is being held in the U.K.

 

and explained the contents of the discussions that were made with AstraZeneca regarding future cooperation plans.

 

According to the Korea Disease Control and Prevention Agency, the G7 Summit is being held in Cornwall, U.K.

 

on the 12th (local time).

 

Korea was invited as a guest nation, and this is the first time in 12 years that a Korean president participated in the G7 Summit.

 

In line with Korea's rising stature, President Moon introduced Korea’s cases in the fields of health and environment at the summit.

 

At the summit, Korea proposed international cooperation plans to fight infectious diseases, in which Korea will act as a global vaccine production hub building on the technical capabilities of the country.

 

Korea's plan to expand contributions to COVAX Advance Market Commitment (AMC) by 20 times, and determination to actively contribute to the inclusive recovery of the international community was also presented at the meeting.

 

During his U.K.

 

visit, the president had also met with Pascal Soriot, CEO of AstraZeneca, for discussions.

 

During the talk, President Moon asked for the company’s continuous support in supplying COVID-19 vaccines to Korea in the second half of this year, and CEO Soriot replied that the company will make its best efforts in consideration of its close partnership with Korea and expressed the company's wish to maintain a long-term manufacturing partnership with SK Bioscience.

 

The government said, “We will do our best to contribute to overcoming the global COVID-19 crisis by ensuring a stable supply of vaccines in Korea while supporting vaccine development and production.”